Dr. Greg Ratliff , MD
Surgery - Plastic and Reconstructive Surgery • Tulsa, OK
2107 E 15th St
Tulsa, OK 741044613
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Greg Ratliff is listed in NPPES under Surgery - Plastic and Reconstructive Surgery.
-
NPI assigned on June 30, 2006; this date does not establish years in practice.
-
Published CMS data list 11 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Cephalexin — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Tulsa, OK (2024, 11 clinicians with data). Median for this group: 67. Middle half: 25 to 118.
Fewer Part D prescriptions than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Oklahoma (2024, 16 clinicians with data). Median for this group: 58. Middle half: 27 to 118.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 12 in 2020 to 11 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
2107 E 15th St
Tulsa, OK 741044613
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Surgery - Plastic and Reconstructive Surgery: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
11 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$44 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $465.15 across 17 records.
By nature of payment
- Food and Beverage: $413.75 across 15 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $51.40 across 2 records.
Reporting-company totals
- ABBVIE INC.: $415.56 across 15 records.
- Galderma Laboratories, L.P.: $49.59 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Tulsa and Oklahoma
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Tulsa, OK (2024, 11 clinicians with data). Median for this group: 67. Middle half: 25 to 118.
Fewer Part D prescriptions than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Oklahoma (2024, 16 clinicians with data). Median for this group: 58. Middle half: 27 to 118.
Part D drug cost
A lower Part D drug cost than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Tulsa, OK (2024, 11 clinicians with data). Median for this group: $552. Middle half: $270 to $781.
A lower Part D drug cost than 95% of clinicians listed under Surgery - Plastic and Reconstructive Surgery in Oklahoma (2024, 16 clinicians with data). Median for this group: $446. Middle half: $271 to $757.
16 active clinicians are listed under Surgery - Plastic and Reconstructive Surgery with a practice address in Tulsa, OK (26 in Oklahoma).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Tulsa
0% of these 16 clinicians have the CMS telehealth indicator.
37.5% of these 16 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 12 in 2020 to 11 in 2024.
- 2020: 12
- 2021: 19
- 2022: 11
- 2023: 29
- 2024: 11
-
30-day fills
30-day fills went from 12 in 2020 to 11 in 2024.
- 2020: 12
- 2021: 19
- 2022: 11
- 2023: 29
- 2024: 11
-
Part D drug cost
Part D drug cost went from $65 in 2020 to $44 in 2024.
- 2020: $65
- 2021: $62
- 2022: $45
- 2023: $177
- 2024: $44
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 93% from $6,738.68 in 2021 to $465.15 in 2025.
- 2021: $6,738.68
- 2022: $2,396.47
- 2023: $1,310.67
- 2024: $492.16
- 2025: $465.15
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 17 records totaling $465.15.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $112.30 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $43.40 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $30.09 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
DYSPORT | General | $29.95 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.32 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $25.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $25.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $22.99 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
— | General | $19.64 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $19.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $19.45 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $17.85 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $17.77 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $17.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $16.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $12.36 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $8.00 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Cephalexin | Cephalexin | 11 | 37 | $43.92 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 2086S0122X
A surgeon who specializes in plastic and reconstructive surgery.
Career & Practice History
NPI enumerated June 30, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Surgery - Plastic and Reconstructive Surgery Specialists in Tulsa
- Dr. Brent Rubis, MD
- Dr. Stephen Paulsen, MD
- Dr. Laurie Duckett, DO
- Dr. Brenda Schiesel, DO
- Angie Hignite, PA-C
- Dr. Rola Eid, DO
Mailing Address
4218 E 72nd St
Tulsa, OK 741366153
Phone: 9182307610